Finerenone for chronic kidney disease in type 2 diabetes

Description

In this Product Explainer, Nephrologist Prof Sunil Badve explains the role of finerenone to delay progressive decline of kidney function in adults with chronic kidney disease (CKD) associated with Type 2 diabetes with albuminuria (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Ron Dick

A/Prof Ron Dick

Why is LDL control important?

Prof Carol Wham

Prof Carol Wham

Malnutrition and frailty in older adults - The importance of screening and early intervention

Prof Andrew Sindone

Prof Andrew Sindone

Heart failure and obesity - Which do we manage first?

Brett Lee

Brett Lee

The social media ban - Practical preparation for children and family

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Sunil Badve

expert

Prof Sunil Badve

Nephrologist; Program Lead, Cardiometabolic Trials, Renal and Metabolic Program, The George Institute for Global Health; Senior Staff Specialist Nephrologist, St George Hospital

Date published: 21 February 2024